Search results
Results from the Health.Zone Content Network
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...
The AstraZeneca vaccine is stable at higher temperatures than the Pfizer-BioNTech vaccine, able to be refrigerated between 35°F (2°C) and 46°F (8°C) rather than stored in an ultra-cold freezer ...
Emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 16 years of age and older.
Takeaway. Dimensions/Getty Images. “Fully vaccinated,” at least in the context of COVID-19, means you have received all the vaccine doses recommended for someone in your demographic. Getting ...
The Bridge Access Program, from the Centers for Disease Control and Prevention (CDC), offers updated Covid-19 vaccines to people who do not have health insurance (or those whose health insurance ...
How to use COVID-19 Vac Mrna,Tris (12Y Up)(Pfizer)(PF) 30 Mcg/0.3 Ml IM Susp(EUA) Read all vaccine information available from your health care professional before receiving the vaccine .
The vaccine should slow the spread of COVID-19 around the world. Fewer people should get sick, and more lives can be saved. The Pfizer, Moderna, and Novavax vaccines have been shown to be at least ...
The COVID-19 mRNA vaccines from Moderna and Pfizer–BioNTech have efficacy rates of 90 to 95 percent [citation needed]. Prior mRNA, drug trials on pathogens other than COVID-19 were not effective and had to be abandoned in the early phases of trials. The reason for the efficacy of the new mRNA vaccines is not clear.